KRAS and neoplasm: The rarity of PDAC development in KC KrasG12D/fl mice, particularly in the context of dramatically increased PanIN burden, indicates that loss of WT Kras facilitates initiation and early lesion formation in the presence of an oncogenic KrasG12D mutation but is not sufficient for tumor progression.